Reminder: Annual Reports to the Office of Laboratory Animal Welfare due December 1, 2020
Notice NOT-OD-21-003 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 1, 2020 Category: Research Source Type: funding
Proposals for Community Instruments and Facilities (CIF)
Letter of Intent Deadline Date: October 21, 2020 Program Guidelines: NSF 20-596The intent of the Community Instruments and Facilities (CIF) solicitation is to provide the NSF-sponsored atmospheric sciences research community with access to specialized instrumentation for field and laboratory-based studies. The CIF solicitation requests proposals from instrument and facility providers who will make their equipment available for community use through an NSF-defined request process. Support will be provided for limited technician time, minor ...More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505...
Source: NSF Upcoming Due Dates - September 21, 2020 Category: Science Source Type: funding
Case Study in Review Integrity: Abuse of Power
A series to raise
awareness, encourage dialog and inspire creative problem solving for challenges
in maintaining integrity in peer review.
What would you do
if, as the Dean of Research at a major university, a group of students,
postdocs, and junior faculty reported that they had been pressured into writing
reviewer critiques for a senior faculty member?
We were so impressed
by the careful handling of just such a situation by an institutional official
recently that we wanted to share this story with you (we’ve changed details and
fictionalized names).
Dr. Lee, Dean of Research at a major research university, rec...
Source: NIH Extramural Nexus - September 2, 2020 Category: Research Authors: Mike Lauer Tags: blog Open Mike Confidentiality Peer review Source Type: funding
NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)
Funding Opportunity PAR-20-288 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites grant applications for the Research Specialist Award (R50) in any area of NCI-funded cancer research. This FOA is specifically for laboratory-based scientists. The Research Specialist Award is designed to encourage the development of stable research career opportunities for exceptional scientists who want to continue to pursue research within the context of an existing NCI-funded basic, translational, clinical, or population science cancer research program, but not serve as independent investig...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 26, 2020 Category: Research Source Type: funding
Notice of Participation in RFA-OD-20-023, "Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional)"
Notice NOT-TR-20-034 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 21, 2020 Category: Research Source Type: funding
Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed)
Funding Opportunity PA-20-252 from the NIH Guide for Grants and Contracts. The rigor and reproducibility of research on dietary supplements is enhanced by rigorous characterization of key experimental resources and biological samples. The dissemination of analytical methods that are validated to accurately and reliably characterize dietary supplements and quantify their constituents and/or metabolites is vital for both basic and clinical research. This FOA builds on existing NIH awards to support the performance and publication of formal single-laboratory validation studies of analytical methods for dietary supplements ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 30, 2020 Category: Research Source Type: funding
An Early Look at Applications Submitted During the Pandemic
It has been four months since the COVID-19
pandemic shuttered
laboratories and clinical studies across the country and the world. On April 10, only a few weeks into the
pandemic, the Congressional Research Service (CRS) published
a report on the “Effects of COVID-19 on the Federal
Research and Development Enterprise.”
The report described the consequences of social distancing and other
pandemic mitigation measures. These
consequences included laboratory closures, de-prioritized projects, cancellation
of meetings and conferences, loss of revenue, disrupted personnel processes
(e.g. graduation, promotio...
Source: NIH Extramural Nexus - July 28, 2020 Category: Research Authors: Mike Lauer Tags: blog Open Mike coronavirus COVID-19 Funding data Source Type: funding
New Vertebrate Animals Section Training Module
Calling all applicants proposing research with vertebrate animals – check out the latest online learning module on the Vertebrate Animals Section in grant applications. This interactive module will assist applicants and offerors in preparing this section of the application, and will serve as a valuable resource for reviewers in evaluating the Vertebrate Animal Section of applications and proposals.
This engaging module takes 30 minutes or less to complete
and includes:
an overview of the requirements, a checklist for applicants and reviewers, detailed instructions, and responsibilities of applicants, re...
Source: NIH Extramural Nexus - July 24, 2020 Category: Research Authors: NIH Staff Tags: New Resources Animal Welfare OLAW Training Source Type: funding
Useful Flexibilities for Animal Care and Use Programs to Comply with the PHS Policy During the COVID-19 Pandemic
As we continue
to address the effects of COVID-19 and as some states and institutions are
considering reopening, we would like to share some administrative flexibilities
that NIH is providing to research institutions with laboratory animal programs.
These flexibilities are
meant to assure personnel safety and animal welfare while enabling research
personnel to prioritize and preserve research efforts. Some of these can be
useful in reducing administrative burden, too.
My colleagues
with the NIH Office of Laboratory Animal Welfare (OLAW), Drs. Catharine Pritchard, Nicolette Petervary, and
Neera Gopee, described these ad...
Source: NIH Extramural Nexus - July 20, 2020 Category: Research Authors: Mike Lauer Tags: blog Open Mike Animal Welfare COVID-19 OLAW Source Type: funding
Addressing Foreign Interference and Associated Risks to the Integrity of Biomedical Research, and How You Can Help
On Tuesday, June 23, Dr. Kelvin Drogemeier,
the Director of the Office of Science and Technology Policy (OSTP), gave a presentation to the Federal
Demonstration Partnership (FDP) on “Enhancing the Security and Integrity of
America’s Research Enterprise.” Dr.
Drogemeier articulated five “key takeaway” messages:
The integrity of our research enterprise rests upon core
principles and values, including transparency, honesty, accountability, objectivity,
respect, freedom of inquiry, reciprocity, and merit-based competition;Principled international collaboration and foreign contributions
are critical to our su...
Source: NIH Extramural Nexus - July 8, 2020 Category: Research Authors: Mike Lauer Tags: blog Open Mike other support Research integrity Source Type: funding
Pediatric Biospecimen Procurement Center (BPC) Supporting the Developmental Gene Expression (dGTEx) Project (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-HD-21-008 from the NIH Guide for Grants and Contracts. The NIH is coordinating efforts for establishing a developmental Genotype-Tissue Expression (dGTEx) project, to catalog and analyze transcriptional profiles from a wide variety of tissues obtained from neonates, children, and adolescents in a post-mortem setting. The purpose of this funding opportunity is for support of a Biospecimen Procurement Center (BPC) to enroll suitable pediatric donors and provide high quality tissue samples for analyses to the Laboratory, Data Analysis, and Coordinating Center (LDACC). The BPC will work closely with ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 23, 2020 Category: Research Source Type: funding
Laboratory, Data Analysis, and Coordinating Center (LDACC) for the Developmental Genotype-Tissue Expression Project(U24) (Clinical Trial Not Allowed)
Funding Opportunity RFA-HG-20-039 from the NIH Guide for Grants and Contracts. The National Human Genome Research Institute (NHGRI) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development are coordinating efforts for establishing a Developmental Genotype-Tissue Expression (dGTEx) project, to catalog and analyze transcriptional profiles from a wide variety of tissues obtained from neonates, children, and adolescents in a post-mortem setting. The purpose of this FOA is to solicit applications to develop and implement a Laboratory, Data Analysis, and Coordinating Center (LDACC) for the Devel...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 19, 2020 Category: Research Source Type: funding
Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01)
Funding Opportunity PAR-20-230 from the NIH Guide for Grants and Contracts. The Center for Inherited Disease Research (CIDR) high-throughput genotyping, sequencing and supporting statistical genetics services are designed to aid the identification of genes or genetic modifications that contribute to human health and disease or to enhance existing collections of well-phenotyped specimens by the addition of genotype or next-generation sequence data. The laboratory specializes in genomic services that cannot be efficiently carried out in individual investigator laboratories. CIDR provides the most up-to-date platforms, ser...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 11, 2020 Category: Research Source Type: funding
Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence (U54 Clinical Trial Optional)
Funding Opportunity RFA-CA-20-038 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is associated with the COVID-19 Supplement funded through the Paycheck Protection Program and Health Care Enhancement Act (P.L. 116-139) which directs the National Cancer Institute of the NIH to develop, validate, improve, and implement serological testing and associated technologies . The purpose of the FOA is to establish Serological Sciences Centers of Excellence with the goal of identifying and advancing research opportunities to characterize the immune responses elicited by SARS-CoV-2 viral inf...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 5, 2020 Category: Research Source Type: funding
Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences (U01 Clinical Trial Optional)
Funding Opportunity RFA-CA-20-039 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is associated with the COVID-19 Supplement funded through the Paycheck Protection Program and Health Care Enhancement Act (P.L. 116-139) which directs the National Cancer Institute of the NIH to develop, validate, improve, and implement serological testing and associated technologies. The purpose of the FOA is to establish Serological Sciences Research Projects with the goals of: identifying and advancing research opportunities to characterize the immune responses elicited by SARS-CoV-2 viral infect...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 5, 2020 Category: Research Source Type: funding
